OYE THERAPEUTICS, INC

Capabilities

OYE Therapeutics, Inc. is a fully integrated small business clinical-stage pharmaceutical company developing sterile injectable therapeutics from preclinical through pivotal stages. Its lead program, a high-concentration intravenous caffeine formulation (250 mg/mL caffeine base), targets reversal of general anesthesia, deep sedation, and opioid-induced respiratory depression. Operating under a Department of War aligned mission, OYE is advancing a dual-use drug product to improve the survivability and recovery in both battlefield and civilian care. With expertise in formulation chemistry, cGMP manufacturing, regulatory strategy and supported by a $20 million DoW collaboration, OYE demonstrates proven success in developing IND-enabling studies, CRADA management, and clinical execution, advancing mission-critical medicines and chemical countermeasures from bench to battlefield to bedside.